Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Serebruany · SciRah

Researcher profile · Semantic Scholar

V. Serebruany

Share profile

V. Serebruany — researcher profile on SciRah

h-index: 48
Works: 461
Citations: 14K

Most-cited papers

Platelet microRNA for predicting acute myocardial infarction
Shuhua Li, L. Guo, Moo-Hyun Kim, Jin-Yeong Han +1 more
2017Journal of Thrombosis and Thrombolysis35 citations
Semantic Scholar
Incidence and Causes for Early Ticagrelor Discontinuation: A “Real-World” Dutch Registry Experience
T. Bergmeijer, P. Janssen, Mathijs van Oevelen, D. V. Van Rooijen +5 more
2017The Cardiology33 citations Open access
Semantic Scholar
Drug Discontinuation and Follow-up Rates in Oral Antithrombotic Trials.
T. Marciniak, Vasily Cherepanov, E. Golukhova, Moo-Hyun Kim +1 more
2016JAMA Internal Medicine27 citations
Semantic Scholar
Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?
V. Serebruany, A. Tomek, Y. Pya, M. Bekbossynova +1 more
2016International Journal of Cardiology23 citations
Semantic Scholar
Impact of renal impairment on platelet reactivity and clinical outcomes during chronic dual antiplatelet therapy following coronary stenting.
L. Guo, Moo-Hyun Kim, Chang Heon Shim, S. Choi +1 more
2016European Heart Journal - Cardiovascular Pharmacotherapy20 citations Open access
Semantic Scholar
Mild COVID-19 and Impaired Blood Cell–Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics?
A. Melkumyants, L. Buryachkovskaya, N. Lomakin, O. Antonova +1 more
2021Thrombosis and Haemostasis18 citations
Semantic Scholar
Mortality and adverse events with brand and generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS).
V. Serebruany, T. S. Hall, D. Atar, S. Agewall +4 more
2018European Heart Journal - Cardiovascular Pharmacotherapy16 citations
Semantic Scholar
CYP2C19 but not CYP2B6, CYP3A4, CYP3A5, ABCB1, PON1 or P2Y12 genetic polymorphism impacts antiplatelet response after clopidogrel in Koreans
Hong-Zhe Zhang, Moo-Hyun Kim, L. Guo, V. Serebruany
2017Blood Coagulation and Fibrinolysis16 citations
Semantic Scholar
Inhibition of Angiotensin II-Induced Cardiac Fibrosis by Atorvastatin in Adiponectin Knockout Mice
S. Choi, Jong Sung Park, M. Roh, Chong-Rak Kim +2 more
2017Lipids16 citations
Semantic Scholar
Validation of Three Platelet Function Tests for Bleeding Risk Stratification During Dual Antiplatelet Therapy Following Coronary Interventions
Moo-Hyun Kim, S. Choi, Soo-Ye-On An, V. Serebruany
2016Clinical Cardiology13 citations Open access
Semantic Scholar
Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
V. Serebruany, J. Tanguay, M. Benavides, H. Cabrera-Fuentes +7 more
2020American Journal of Therapeutics12 citations Open access
Semantic Scholar
Atrial Fibrillation and Stroke in Patients with Hypertrophic Cardiomyopathy: Important New Insights
J. Borer, D. Atar, T. Marciniak, Moo-Hyun Kim +1 more
2019Thrombosis and Haemostasis12 citations Open access
Semantic Scholar
Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy
E. Golukhova, M. Grigoryan, Mariya N. Ryabinina, N. Bulaeva +1 more
2018The Cardiology12 citations
Semantic Scholar
Noninvasive Predictors of Malignant Arrhythmias
E. Golukhova, O. Gromova, M. Grigoryan, V. Merzlyakov +3 more
2016The Cardiology12 citations
Semantic Scholar
Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19
A. Melkumyants, L. Buryachkovskaya, N. Lomakin, O. Antonova +3 more
2022Journal of Clinical Medicine10 citations Open access
Semantic Scholar
Worldwide reporting of fatal outcomes after ticagrelor to the US Food and Drug Administration
V. Serebruany, Moo-Hyun Kim, T. Marciniak
2018European Heart Journal - Cardiovascular Pharmacotherapy10 citations Open access
Semantic Scholar
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
N. Lomakin, A. Rudakova, L. Buryachkovskaya, V. Serebruany
2018European Cardiology10 citations Open access
Semantic Scholar
Assessing Vessel Tone during Coronary Artery Spasm by Dual-Acquisition Multidetector Computed Tomography Angiography
C. Jin, Moo-Hyun Kim, E. Kang, Young-Rak Cho +3 more
2017The Cardiology10 citations
Semantic Scholar
Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
V. Serebruany, Vasily Cherepanov, Seth D. Fortmann, Moo-Hyun Kim
2017Open Heart10 citations Open access
Semantic Scholar
Should We Use Tegaserod for Irritable Bowel Syndrome?
T. Marciniak, V. Serebruany
2019American Journal of Therapeutics9 citations
Semantic Scholar
Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet Therapy
S. Choi, Moo-Hyun Kim, V. Serebruany
2018TH Open9 citations Open access
Semantic Scholar
Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy
L. Guo, Moo-Hyun Kim, Tae Hyung Kim, Jong Seong Park +4 more
2016Nephron9 citations
Semantic Scholar
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.
T. V. von Lueder, D. Atar, S. Agewall, J. K. Jensen +5 more
2019American Journal of Therapeutics8 citations Open access
Semantic Scholar
Annual adverse event profiles after clopidogrel, prasugrel, and ticagrelor in the Food and Drug Administration Adverse Event Reporting System
Vasily Cherepanov, Seth D. Fortmann, MD HyunKim, T. Marciniak +3 more
2018European Heart Journal - Cardiovascular Pharmacotherapy8 citations Open access
Semantic Scholar
Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
V. Serebruany, Moo-Hyun Kim, H. Cabrera-Fuentes, K. Lee +5 more
2017Thrombosis and Haemostasis8 citations
Semantic Scholar
Troponin I and D-Dimer for Discriminating Acute Pulmonary Thromboembolism from Myocardial Infarction
S. Kim, Moo-Hyun Kim, K. Lee, Tae Hyung Kim +4 more
2016The Cardiology8 citations
Semantic Scholar
Predicting Successful Recanalization in Patients with Native Coronary Chronic Total Occlusion: The Busan CTO Score
C. Jin, Moo-Hyun Kim, S. Kim, K. Lee +3 more
2017The Cardiology7 citations
Semantic Scholar
CRUSADE Score is Superior to Platelet Function Testing for Prediction of Bleeding in Patients Following Coronary Interventions
Junghee Bang, S. Choi, Moo-Hyun Kim, V. Serebruany
2017EBioMedicine7 citations Open access
Semantic Scholar
Concomitant nitrates enhance clopidogrel response during dual anti-platelet therapy.
Dong Hyun Lee, Moo-Hyun Kim, L. Guo, C. Jin +5 more
2016International Journal of Cardiology7 citations
Semantic Scholar
The challenge for predicting bleeding events by assessing platelet reactivity following coronary stenting.
S. Choi, Moo-Hyun Kim, V. Serebruany
2016International Journal of Cardiology7 citations
Semantic Scholar
Ranolazine, ACE Inhibitors, and Angiotensin Receptor Blockers.
T. Marciniak, V. Serebruany
2019American Journal of Medicine6 citations
Semantic Scholar
Misreported Cancer Deaths in PLATO Trial
V. Serebruany, J. Tanguay
2021Journal of Clinical Medicine5 citations Open access
Semantic Scholar
Excess Ticagrelor Mortality in the Food and Drug Administration Adverse Event Reporting System: Time to Recount PLATO Trial Deaths.
V. Serebruany, Seth D. Fortmann, Vasily Cherepanov, O. Litvinov +2 more
2017American Journal of Medicine5 citations Open access
Semantic Scholar
Vorapaxar and Amyotrophic Lateral Sclerosis: Coincidence or Adverse Association?
V. Serebruany, Seth D. Fortmann, D. Hanley, Moo-Hyun Kim
2017American Journal of Therapeutics5 citations
Semantic Scholar
Long-term clinical outcomes after successful and failed recanalization to native chronic Total occlusion: Insights from the Busan chronic Total occlusion (B-CTO) Registry.
Moo-Hyun Kim, K. Mitsudo, C. Jin, Tae Hyung Kim +5 more
2016Cardiovascular Revascularization Medicine5 citations
Semantic Scholar
Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation
V. Serebruany, Seth D. Fortmann, Sunil V. Rao, J. Tanguay +5 more
2016Thrombosis and Haemostasis5 citations
Semantic Scholar
Impact of olokizumab on platelets, leukocytes and erythrocytes during mild COVID-19.
L. Buryachkovskaya, N. Lomakin, A. Melkumyants, Julia Docenko +1 more
2021Reviews in cardiovascular medicine4 citations Open access
Semantic Scholar
Impact of marital status on outcomes following ST-segment elevation myocardial infarction.
Moo-Hyun Kim, K. Lee, S. Kim, So Yeon Kim +6 more
2017Cardiovascular Revascularization Medicine4 citations
Semantic Scholar
A Prospective, Randomized, Open-Label, Blinded, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with the Acute Coronary Syndrome: HOPE-TAILOR Study
C. Jin, Moo-Hyun Kim, Junghee Bang, V. Serebruany
2017The Cardiology4 citations
Semantic Scholar
Thienopyridine reloading in clopidogrel-loaded patients undergoing percutaneous coronary interventions: The PRAISE study.
L. Guo, Moo-Hyun Kim, E. Shin, S. Ann +7 more
2016International Journal of Cardiology4 citations
Semantic Scholar
Adjunctive Cilostazol in Patients With High Residual Platelet Reactivity After Drug-Eluting Stent Implantation: A Randomized, Open-Label, Single-Center, Prospective Study (ADJUST-HPR)
Guo-Long Zhe, Long-Hau Yu, Dong-Hyun Lee, M. Kim +1 more
2023American Journal of Therapeutics3 citations
Semantic Scholar
Tocilizumab, blood cells, and mild COVID-19: delayed vascular protection by interleukin blockade?
L. Buryachkovskaya, N. Lomakin, A. Melkumyants, Julia Docenko +1 more
2021European Heart Journal - Cardiovascular Pharmacotherapy3 citations Open access
Semantic Scholar
The FDA and PLATO Investigators death lists: Call for a match
V. Serebruany, J. Tanguay, T. Marciniak
2021International journal of clinical practice3 citations Open access
Semantic Scholar
Predicting bleeding risk by simplified PRECISE-DAPT score.
S. Choi, Moo-Hyun Kim, S. Yun, V. Serebruany
2020Thrombosis Research3 citations
Semantic Scholar
Challenging Anticoagulation in Advanced Renal Failure.
H. Marti, V. Serebruany, D. Atar
2019American Journal of Medicine3 citations Open access
Semantic Scholar
Are drug regulators really too slow?
T. Marciniak, V. Serebruany
2017British medical journal3 citations
Semantic Scholar
Aspirin in the Food and Drug Administration Adverse Event Reporting System: Missing Demographics and Underreporting
V. Serebruany, A. Tomek, Moo-Hyun Kim, O. Litvinov +1 more
2017TH Open3 citations Open access
Semantic Scholar
Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS)
V. Serebruany, Vasily Cherepanov, Moo-Hyun Kim, O. Litvinov +2 more
2017The Cardiology3 citations
Semantic Scholar
Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial
V. Serebruany, Moo-Hyun Kim, D. Hanley
2016International Journal of Stroke3 citations
Semantic Scholar
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?
V. Serebruany, A. Tomek
2016International Journal of Cardiology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Moo-Hyun Kim×32
Invite
Moo-Hyun Kim — researcher profile on SciRah
T. Marciniak×14
Invite
T. Marciniak — researcher profile on SciRah
S. Choi×8
Invite
S. Choi — researcher profile on SciRah
Young-Rak Cho×7
Invite
Young-Rak Cho — researcher profile on SciRah

×6

Invite

L. Guo — researcher profile on SciRah

Invite

C. Jin — researcher profile on SciRah

Invite

T. Park — researcher profile on SciRah

Vasily Cherepanov×5

Invite

Vasily Cherepanov — researcher profile on SciRah

Invite

N. Lomakin — researcher profile on SciRah

Seth D. Fortmann×5

Invite

Seth D. Fortmann — researcher profile on SciRah

Kyungil Park×5

Invite

Kyungil Park — researcher profile on SciRah

A. Melkumyants×4

Invite

A. Melkumyants — researcher profile on SciRah